Alexander Nowak
Stock Analyst at Craig-Hallum
(2.63)
# 2,016
Out of 4,829 analysts
48
Total ratings
41.67%
Success rate
5.32%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $4.77 | +361.22% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $151.95 | +3.32% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $6.68 | +154.49% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $36.36 | +56.77% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $10.15 | +166.01% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $15.36 | -2.34% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $3.66 | +118.58% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $0.15 | +575.68% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $3.37 | +434.12% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $22.98 | +117.58% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.74 | +978.02% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $51.63 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.62 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.13 | +416.43% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $49.94 | +120.26% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.63 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.00 | +9,900.00% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $5.37 | +421.42% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $4.77
Upside: +361.22%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $151.95
Upside: +3.32%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.68
Upside: +154.49%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $36.36
Upside: +56.77%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $10.15
Upside: +166.01%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $15.36
Upside: -2.34%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $3.66
Upside: +118.58%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $0.15
Upside: +575.68%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $3.37
Upside: +434.12%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $22.98
Upside: +117.58%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.74
Upside: +978.02%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $51.63
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.13
Upside: +416.43%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $49.94
Upside: +120.26%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.63
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.00
Upside: +9,900.00%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $5.37
Upside: +421.42%